A part of Burjeel Medical City’s integrated healthcare ecosystem, the institute offers precise, personalized, and holistic care on par with international standards for patients across all age groups 

Abu Dhabi: In a bid to meet the growing demand for advanced ophthalmic care in the emirate, Burjeel Medical City (BMC), the flagship facility of Burjeel Holdings, has launched the Burjeel Eye Institute, a specialized center offering a wide spectrum of diagnostic and treatment services for eye diseases. A part of the integrated healthcare ecosystem of BMC, the institute offers precise, personalized, and holistic care on par with international standards for patients across all age groups. 

The launch event was attended by Dr. Shamsheer Vayalil, Chairman and CEO of Burjeel Holdings; Mr. Khaled Ateeq Aldhaheri, Chief Executive Officer of Daman; Colonel Dr. Abdulaziz Jaber Mohammed Al Shareef, Deputy Director of the Medical Services Department, Abu Dhabi Police; Dr. Khawla Al Nasseri, Quality Assurance Director, DoH; and Dr. Mujtaba Ali Khan, CEO, Burjeel Medical City. 

Comprehensive, Personalized Care in Focus 

Led by Dr. Murad Manea Alobthani, Consultant Ophthalmologist and Head of the Burjeel Eye Institute, the institute aims to strengthen access to specialized ophthalmic services in Abu Dhabi, particularly amid the rising prevalence of age-related eye diseases, diabetes-related eye conditions, and retinal disorders.  

“The institute’s launch marks a significant milestone in the development of ophthalmic services in Abu Dhabi. Our goal is to provide comprehensive and advanced eye care based on the latest scientific advancements in diagnosis and surgical treatment, with a strong focus on patient safety and quality outcomes. Through this institute, we aim to preserve vision, improve patients’ quality of life, and deliver services that match the standards of leading global centers, without the need for patients to seek treatment abroad,” said Dr. Murad. 

World-Class Eye Care for Every Patient  

The institute’s services span multiple subspecialties, including cataract surgery and vision correction, retinal and vitreous diseases and surgeries, glaucoma management, corneal and ocular surface diseases, pediatric ophthalmology and strabismus, as well as oculoplastic and eyelid surgeries and optic nerve disorders. 

It is equipped with state-of-the-art facilities, advanced diagnostic devices, and cutting-edge surgical technologies. These include advanced laser systems, high-resolution imaging for the retina and optic nerve, and fully equipped operating theaters designed to perform the most delicate ophthalmic surgeries in accordance with the highest standards of safety and quality. This infrastructure enables the delivery of personalized treatment plans tailored to each patient’s individual needs. 

“The launch of the institute aligns with Burjeel Medical City’s commitment to supporting the UAE’s healthcare ecosystem and reinforcing its position as a leading center for specialized and highly specialized medical care. This is in line with Abu Dhabi’s vision to provide world-class, patient-centered healthcare services that prioritize quality of life,” said Dr. Mujtaba Ali Khan. 

The medical team comprises highly experienced Emirati ophthalmologists across various subspecialties, including Dr. Murad; Dr. Mohammed Khalfan Al Ketbi, Consultant in Vitreoretinal Surgery and Uveitis; Dr. Ahmed Al Ne yadi, Consultant Ophthalmologist, Specialist in Refractive Surgery; Dr. Sumayya Jumaa Al Marzouqi, Consultant Neuro-Ophthalmologist; Dr. Abeer Al Ali, Consultant Pediatric Ophthalmologist; and Dr. Ashwaq Bin Amro, Consultant Ophthalmologist. They are supported by a multidisciplinary team with expertise in laser vision correction, retinal diseases, pediatric ophthalmology, and glaucoma, reflecting the institute’s commitment to delivering comprehensive, team-based specialized care. 

During the launch, the Burjeel Eye Institute announced a collaboration with Oftalvist, a renowned ophthalmology group in Spain and a leader in comprehensive eye care and treatment. A Memorandum of Understanding was signed by Dr. Murad Manea Alobthani and Dr. Juan Alvarez de Toledo.

Chairman and CEO Dr. Shamsheer Vayalil announces major frontliner recognition fund during leadership address in Abu Dhabi

Abu Dhabi, January 20, 2026: What was planned as a leadership address became an emotional moment for thousands of healthcare workers as Burjeel Holdings Chairman and CEO Dr. Shamsheer Vayalil announced AED 15 million financial recognition fund during a Group-wide town hall attended by more than 8,500 employees at Etihad Arena.

The gathering marked a first-of-its-kind moment in the UAE, with one of the country’s largest CEO-led employee town halls bringing together frontline staff, clinicians, nurses, allied health professionals, and support teams under one roof. Midway through the address, employees’ phones began buzzing with SMS notifications confirming their inclusion in the newly launched BurjeelProud recognition initiative, prompting sustained applause across the arena.

“This is not a reward for a department. This is not tied to conditions. This is not because you asked. This is because you are the people on the ground,” Dr. Shamsheer told employees.

AED 15 Million Surprise for Frontliners

Close to 10,000 frontline employees will benefit from the first phase of the initiative, covering nearly 85 percent of Burjeel Holdings’ nursing, allied health, patient care, operations, and support workforce. The financial recognition is expected to be equivalent to approximately half a month to one month of basic salary, depending on role and category.

“This country gave us the opportunity to grow. And when a country gives you that opportunity, you carry a responsibility to give back with action,” he said.

He described frontliners as central to Burjeel’s identity and future direction. “I will not be able to stand here if you are not there on the ground,” he told employees.

The announcement came as a surprise to many in attendance, with several frontline staff seen emotional as the timing and message became clear. “It was a real surprise. It felt like a moment for all of us on the frontline,” said one nurse after the event.

The recognition initiative forms part of Burjeel Holdings’ next phase of growth, Burjeel 2.0, with a focus on execution, accountability, and people-led growth.

Burjeel Medical City to Evolve into Next-gen Ecosystem

The address also outlined Burjeel’s 2030 vision for Burjeel Medical City (BMC), which will evolve into a next-generation medical city ecosystem in Mohammed Bin Zayed City. The expansion aims to move beyond a traditional hospital model by integrating complex clinical care with research, medical education, rehabilitation, and patient-centered living environments.

“I still remember standing with a small model of Burjeel Medical City and sharing that vision with His Highness Sheikh Mohamed bin Zayed Al Nahyan during his visit years ago. It was only a

dream then. Today, it stands as one of the most important healthcare institutions in the region,” Dr. Shamsheer said.

Aligned with Abu Dhabi’s long-term healthcare strategy, the BMC vision includes an advanced academic medical model combining patient care, education, and research, alongside specialized institutes such as sports medicine and rehabilitation services.

The recognition positions the Group as a national and regional leader in advanced nursing education 

Abu Dhabi: Burjeel Holdings, a leading super-specialty healthcare services provider in MENA, has achieved a landmark milestone in healthcare education and workforce development by securing the National Institute for Health Specialties’ (NIHS) accreditation for its Adult Critical Care Nursing Residency Program.  

It is the first NIHS-accredited Nursing Residency Program in the UAE and the region, and the first officially recognized nursing residency program in the country, positioning the Group as a national and regional pioneer in advanced nursing education. 

“The accreditation reflects Burjeel Holdings’ commitment to advancing healthcare education and building sustainable national capabilities. Investing in structured, accredited training, particularly in critical care nursing, is essential to strengthening healthcare quality, resilience, and patient safety across the UAE and the wider region,” said Dr. Shamsheer Vayalil, Chairman and CEO of Burjeel Holdings. 

Dr. Mohamed Al Houqani, Secretary General of NIHS, said that the accreditation represents an important milestone in regulated nursing education in the UAE. “It reflects NIHS’ commitment to strengthening specialty-based training, elevating professional practice standards, and supporting a sustainable, highly skilled healthcare workforce that meets national priorities and international benchmarks,” he said. 

Residency Program to Empower Nursing Workforce  

The residency program prepares nurses for advanced clinical practice in Adult Critical Care, in alignment with national regulatory requirements and international best practices. Graduates will receive NIHS accreditation in the specialty of Adult Critical Care Nursing, enabling them to practice at the highest standards of clinical excellence. 

Beyond its accreditation significance, this program represents a fundamental shift in the nursing practice model in the UAE. By transitioning from task-based nursing roles to structured, competency-based, residency-trained practice, the program strengthens clinical decision-making, professional accountability, and interdisciplinary collaboration. This approach directly contributes to improved patient outcomes, enhanced quality of care, and safer critical care environments. 

“This program represents a milestone in our journey to reshape medical education in the UAE. By embedding structured, nationally accredited residency training into nursing career pathways, we are raising professional standards, strengthening quality and safety in critical care, and building a strong, sustainable nursing workforce equipped for the future of healthcare,” commented Dr. Tahani Al Qadiri, Director of Emiratization and Academic Affairs at Burjeel Holdings. 

Investing in medical education will ensure long-term workforce sustainability by establishing a clear professional career pathway for healthcare professionals, supporting retention, specialization, and leadership development. Through nationally accredited residency training, the program reduces reliance on ad hoc upskilling models and creates a future-ready workforce aligned with the UAE’s healthcare transformation agenda.  

This achievement builds on Burjeel Holdings’ proven leadership in medical education, marked by a series of nationally recognized milestones. Over recent years, the Group has successfully secured multiple NIHS accreditations across residency and fellowship programs, including the internal medicine, general surgery, orthopedic, and hematology-oncology programs. It established structured competency-based training pathways and expanded accredited education within the private healthcare sector.   

Through this achievement, Burjeel Holdings continues to set new benchmarks in healthcare education, reinforcing its leadership in clinical excellence, accredited training, quality improvement, and national workforce sustainability. 

BCI achieved a flawless result with no findings or non-conformities, marking an exceptional accomplishment

Abu Dhabi, November 13, 2025: In a landmark medical achievement, Burjeel Cancer Institute’s (BCI) Breast Cancer Clinical Care Program has received the Gold Certification from the Joint Commission International (JCI). The JCI Gold Certification, considered a global benchmark in healthcare excellence, is granted only to institutions that demonstrate the highest international standards in clinical care delivery. The accreditation acknowledges BCI’s strong commitment to continuously improving the delivery of quality healthcare services.

As part of the evaluation process, JCI’s expert panel visited the institute for a comprehensive and rigorous assessment. It involved an in-depth review of compliance with 164 measurable standards covering all aspects of cancer care, including leadership and governance, care delivery, patient safety, information and medication management, staff training and competency, as well as patient and family education.

BCI distinguished itself by achieving a flawless result with no findings or non-conformities, marking an exceptional accomplishment that highlights the dedication and professionalism of its team in delivering world-class cancer care.

Commenting on the achievement, Prof. Humaid bin Harmal Al Shamsi, CEO of BCI, said, “Receiving the JCI Gold Certification for our Breast Cancer Program is an international endorsement of the quality of care we provide and our commitment to advancing healthcare excellence in our region. This recognition is not merely an institutional milestone; it is a renewed promise to our patients that we remain devoted to offering comprehensive, safe, and compassionate care that meets global standards. We take pride in leading innovation and excellence in cancer care.”

The certification provides a robust institutional framework to enhance patient experience, improve staff efficiency, and ensure consistent and safe healthcare delivery. It also supports patient-centered care strategies and reinforces the institute’s commitment to addressing the physical, psychological, and social needs of patients and their families.

Established in 1994 as an affiliate of the Joint Commission (USA), Joint Commission International (JCI) is a globally recognized leader in healthcare accreditation. Operating in more than 70 countries, JCI promotes quality improvement and patient safety through rigorous accreditation programs and internationally recognized standards. For more information, visit: www.jointcommissioninternational.org

The Group won awards in the ‘Establishments’ and ‘Outstanding Workforce’ categories, reaffirming its commitment to developing a dynamic and healthy workplace 

Abu Dhabi, November 14, 2025: Strengthening its reputation for workplace excellence, Burjeel Holdings, a leading super-specialty healthcare provider in the MENA region, has secured two awards at the third edition of the prestigious Emirates Labour Market Awards. Organized by the Ministry of Human Resources and Emiratisation (MOHRE), the ceremony was held under the patronage of His Highness Sheikh Mansour bin Zayed Al Nahyan, Vice President, Deputy Prime Minister, and Chairman of the Presidential Court. 

In the Establishments category, LLH Hospital, Abu Dhabi, received recognition in the Healthcare Company sub-category. For LLH Hospital, this marks a hat-trick win at the Labour Market Awards. In the inaugural edition, it was honored for its outstanding achievement in Workforce Well-being and the Quality of Life category, followed by the Establishments — Healthcare and Social Work category in the second edition.  

The Group also excelled in the Outstanding Workforce category, with Anas Kadiyarakam, Regional HR Manager at Burjeel Holdings, securing first place in the Management and Executives sub-category. He received a cash prize of one hundred thousand dirhams, an Apple Watch, a gold coin, and a Fazaa privilege card.  

The winners were honoured by His Highness Theyab bin Mohamed bin Zayed Al Nahyan, Deputy Chairman of the Presidential Court for Development and Fallen Heroes’ Affairs. 

Anas, a first-time recipient of this award, said that it’s a proud milestone in his career. He started his journey at Burjeel Holdings in 2009 as an HR Executive. From there, he was promoted to the roles of HR Officer, Assistant Manager, and then Manager. Currently, he serves as the Regional HR Manager, overseeing hospitals and international projects across the region. “I feel so honored to receive this prestigious award. I consider it a recognition from the UAE for being part of its labor force for the past 16 years. I’m also thankful to the Burjeel family for providing me with amazing opportunities that have catalyzed my career growth and enabled me to contribute to the overall development of the nation. This award also serves as a powerful reminder to continue creating a healthy workplace where people can thrive,” he said. 

Reflecting on the achievement, Dr. Tahani Al Qadiri, Group Director of Emiratization and Academics at Burjeel Holdings, said, “We feel immensely proud to receive this esteemed recognition once again, which honors the continuous efforts we put forward in building an inclusive, sustainable, and empowering workplace. At Burjeel Holdings, we remain focused on investing in our people, as we know they are the driving force behind exceptional care and innovation in healthcare. This honor inspires us to continue cultivating a healthy workforce and, in doing so, contribute to the UAE’s vision of cultivating world-class work environments.” 

The winners, comprising companies and individuals, were chosen from over 18,000 applications, reviewed by expert committees using comprehensive and integrated criteria. 

Over 700 specialists gather at the Fourth Emirates Pediatric BMT and Gene Therapy Congress to share breakthroughs, celebrate treatment success, and strengthen the UAE’s position as a hub for advanced pediatric care. 

Abu Dhabi, November 8, 2025: Reinforcing the UAE’s ambition to emerge as a global leader in advanced pediatric care and its growing reputation as a hub of medical excellence and innovation, Abu Dhabi hosted the Fourth Emirates Pediatric Bone Marrow Transplantation and Gene Therapy Congress, which opened today at the Grand Hyatt Abu Dhabi Hotel & Residences. The two-day congress brings together global leaders in pediatric hematology, oncology, and cellular therapy, underscoring the nation’s vision to position itself at the forefront of complex and life-saving medical treatments. 

This year’s congress, themed “An International Get-Together of Pediatric BMT Physicians to Celebrate the Success of Saving Children Globally,” reflects the spirit of collaboration and shared progress that defines the global pediatric bone marrow transplant community. The theme highlights the dedication of physicians, researchers, and healthcare institutions working together to advance curative treatments for children with rare and life-threatening blood disorders. 

A Two-Day Comprehensive Scientific Program 

The congress brings together more than 700 delegates and over 30 distinguished speakers from across 30 countries, including the United States, the United Kingdom, Spain, France, Italy, Saudi Arabia, India, and Jordan. Participating institutions include Burjeel Medical City (BMC), Children’s Hospital of Philadelphia, Cincinnati Children’s Hospital, Children’s Hospital Los Angeles, and SJD Barcelona Children’s Hospital. 

This year’s congress features a comprehensive scientific program encompassing keynote lectures, expert panels, oral and poster presentations, and industry symposia. Topics being discussed include the latest advances in gene therapy for thalassemia and sickle cell disease, haploidentical and matched sibling transplantation, CAR-T cell therapy, and transplant immunology. Sessions also explore donor stem-cell manipulation, supportive care, long-term survivorship, and regional access to cell and gene therapy innovations. 

The congress also focuses on the UAE’s growing contributions to regional healthcare advancement, including the development of national stem cell donor registries, collaboration with the Abu Dhabi Biobank to enhance cell therapy research, and strategies to increase access to gene therapy and transplantation across the Gulf region. 

Ahead of the main sessions, the Pediatric Bone Marrow Transplant Course 2025 offered intensive hands-on and theoretical training for young clinicians and researchers in pediatric transplantation. Led by international faculty, the course covered donor selection, stem cell harvesting and cryopreservation, conditioning regimens, and post-transplant management, equipping participants with practical skills to strengthen regional capacity. 

“This congress reflects how far we have come as a region in advancing pediatric transplantation and gene therapy. Supporting this significant event, our goal at BMC, is to provide children and families in the UAE and across the region with access to the best possible care, without the need to travel abroad. Along with the treatment center we are strengthening research, and collaboration that drives new standards in pediatric care,” said Dr. Zainul Aabideen, Congress Chair and Head of Pediatric Hematology, Oncology, and Bone Marrow Transplantation at Burjeel Cancer Institute, BMC. 

Dr. Aabideen presented to the delegates how BMC, which became home to the UAE’s first comprehensive pediatric bone marrow transplant program, has achieved survival rates of over 90 percent in the past three years. The milestone underscores Abu Dhabi’s emergence as a regional referral destination for complex pediatric cases and aligns with the UAE’s broader healthcare strategy to build self-sufficiency through advanced clinical capabilities and local talent development. 

Delegates reaffirmed their shared goal of advancing knowledge, expanding research collaboration, and accelerating access to gene therapy for children with rare and inherited disorders. With its focus on innovation, education, and global partnership, the congress celebrates the collective success of pediatric bone marrow transplant programs worldwide and underscores the UAE’s leadership in shaping the future of pediatric medicine. 

KSA Health Minister HE Fahad Abdulrahman AlJalajel, felicitated Dr. Shamsheer Vayalil, Founder and Chairman of the Group, for initiatives advancing healthcare transformation in line with Vision 2030.

Riyadh, October 28, 2025: Burjeel Holdings, a leading super-specialty healthcare services provider in MENA, unveiled a suite of advanced artificial intelligence (AI) solutions at the Global Health Exhibition 2025 in Riyadh, underscoring its commitment to transforming patient care and advancing Saudi Arabia’s healthcare ecosystem.

During the opening ceremony, HE Fahad Abdulrahman AlJalajel, Minister of Health, felicitated Dr. Shamsheer Vayalil, Founder and Chairman of Burjeel Holdings, for the Group’s initiatives that advance healthcare transformation in line with Saudi Arabia’s Vision 2030.

Integrating Care and Intelligence

Under the theme ‘Care & Intelligence – World-Class Healthcare for the Kingdom,’ Burjeel Holdings is showcasing how technology, data, and empathy converge to redefine healthcare experiences. The Group is demonstrating a new generation of AI-driven innovations designed to elevate patient outcomes, streamline clinical workflows, and support wellness through personalized, data-informed care models.

“The Global Health Exhibition provides an important platform to demonstrate how care and intelligence can come together to reshape the healthcare experience. With these integrated AI-driven healthcare innovations, we are building a smarter, more compassionate healthcare future that meets the evolving needs of our patients and communities. Our goal is to seamlessly blend cutting-edge technology with human-centered care to elevate health outcomes and quality of life across the region,” said Mr. Safeer Ahamed, Co-CEO of Burjeel Holdings.

The newly introduced AI solutions span a wide spectrum of applications, from digital rehabilitation platforms that enable patients to undergo guided physiotherapy from home to intelligent surgical systems that connect specialists virtually to perform and supervise procedures in real time. These innovations combine clinical expertise with automation and analytics to ensure accuracy, safety, and accessibility in every phase of care.

Another key innovation focuses on predictive and personalized health management. Through data modeling and biomarker analysis, the Group’s new digital health platforms can identify early risks, optimize preventive care, and generate tailored lifestyle and nutrition insights. This approach allows clinicians to transition from reactive to proactive care models, improving health outcomes and patient satisfaction.

Advancing Personalized, Preventive, and Mental Health Solutions

In musculoskeletal and rehabilitation care, Burjeel Holdings continues to deploy personalized and digital therapeutics that deliver home-based physiotherapy and pain management programs. These solutions use real-time monitoring to ensure continuous recovery support and data-driven therapy optimization.

In specialty and complex care, the Group continues to advance precision medicine through diagnostic and therapeutic programs that leverage molecular and clinical data. Collaborations

with international partners and ongoing clinical trials are helping bring personalized treatments and innovative therapies to patients across the region.

To promote holistic health and longevity, Burjeel Holdings is introducing digital platforms that combine genetic, biomarker, and lifestyle data to provide actionable insights and personalized recommendations for nutrition, fitness, and preventive care. Complementing these initiatives, the Group is integrating empathetic AI-powered companions that support mental and emotional well-being through guided assistance and culturally attuned digital engagement.

Across its facilities, the Group is also integrating generative AI tools that improve clinical workflows and communication between patients and care teams. These intelligent systems enhance efficiency, safety, and patient experience, reflecting the Group’s vision to make healthcare more connected, compassionate, and data-driven.

Since entering the Kingdom three years ago, Burjeel Holdings has evolved from a regional healthcare leader to a trusted local partner. Its brands, including PhysioTherabia and Al Kalma, have established a strong presence across wellness and mental health services. Al Kalma’s recent acquisition of a leading mental health facility in Riyadh further underscores the Group’s dedication to expanding access to emotional and psychological support. Burjeel Holdings is also preparing to open two new day surgery centers in Riyadh and Al Khobar under its Burjeel One brand, offering world-class outpatient and same-day surgical care.

These innovations reflect Burjeel Holdings’ vision of building a more connected, efficient, and patient-centric healthcare ecosystem across the Kingdom. The solutions are being integrated within the Group’s expanding network across the region to improve access, enhance clinical training, and reduce the burden of chronic and lifestyle-related diseases. These developments reinforce the Group’s role as a key contributor to Saudi Arabia’s efforts to localize advanced healthcare capabilities and expand digital health infrastructure.

Located inside Al Falah Central Mall, the new Center strengthens Burjeel Holdings’ primary care network across Abu Dhabi and connects residents with its world-class healthcare network 

Abu Dhabi, October 24, 2025: Further strengthening its commitment to deliver world-class healthcare within reach of every community in Abu Dhabi, Burjeel Holdings, a leading super-specialty healthcare services provider in MENA, has announced the opening of its newest facility, Burjeel Medical Center, Al Falah. 

H.E. Dr. Saif Sultan Al Nasri, Undersecretary of the Department of Municipalities and Transport, inaugurated the new Center, located inside Al Falah Central Mall. The launch event was attended by H.E. Dr. Fayeza Saif Alyafei, Executive Director of the Healthcare Quality Sector at the Department of Health – Abu Dhabi; Dr. Shamsheer Vayalil, Founder and Chairman of Burjeel Holdings; Omran Al Khoori, Member of the Board of Directors, Burjeel Holdings; and John Sunil, CEO of Burjeel Holdings. 

The launch of Burjeel Medical Center, Al Falah, marks a significant step in Burjeel Holdings’ strategy to strengthen its network of primary care centers across Abu Dhabi. The new facility reinforces the Group’s goal of building a seamless and connected healthcare ecosystem where residents can access trusted medical care within their neighborhoods and, when needed, benefit from referrals and continuity of care through Burjeel’s hospitals and specialized centers. The new Center is further connected with Burjeel Medical City, the Group’s flagship quaternary care center, ensuring patients have access to advanced specialty and complex care services within the same integrated network. 

Al Falah’s strong community spirit and family-oriented lifestyle make it an ideal location for Burjeel to expand its compassionate and comprehensive healthcare model. The Center is expected to elevate the healthcare landscape in the area by offering accessible, family-centered medical services that promote wellness, prevention, and early intervention. With a focus on family health, continuity of care, and personalized service, the Center seeks to build healthier and happier neighborhoods across Abu Dhabi. 

The facility offers a wide range of specialties, including Family Medicine, Internal Medicine, Pediatrics, and Obstetrics and Gynecology. Notably, mental health and wellness services are integrated into primary care, ensuring patients receive holistic support that addresses both physical and emotional well-being as part of their everyday healthcare journey. The Center is equipped with advanced diagnostic and support services, including Ultrasound, X-Ray, IV infusions, pharmacy, phlebotomy, and point-of-care testing. Additionally, it offers preventive screenings, smoking cessation programs, autism screening and support, and immunization and vaccination services. 

John Sunil, CEO of Burjeel Holdings, said the new Center represents a key milestone in the Group’s ongoing mission to strengthen the primary care foundation of Abu Dhabi’s healthcare system. “At Burjeel Holdings, we believe primary care is the cornerstone of a strong healthcare network. By expanding our reach through centers like Burjeel Medical Center, Al Falah, we are ensuring that every community has access to trusted medical expertise and smooth referral pathways into our specialized hospitals. This approach not only improves access but also enhances the overall patient experience through continuity and quality of care,” said John Sunil. 

Dr. Khuloud Al Zubaidi, Medical Director and Specialist in Family Medicine, said, “Our aim is to bring the highest standard of healthcare right into the community, so families can receive expert care without having to travel far. We want every visit to be defined by trust, accessibility, and personalized attention.” 

Beyond clinical services, the Center will play an active role in community engagement. It will lead year-long programs focused on preventive care, early detection, and health awareness, hosting educational sessions and screening campaigns to encourage residents to prioritize their well-being and adopt healthier lifestyles.

With nine successful surgeries, the 10 Journeys Initiative, the humanitarian program initiated by Dr. Shamsheer Vayalil, continues to transform lives across the world 

Abu Dhabi, October 09, 2025: When Australian dog trainer Amanda De Jong first began losing control of her left leg, she thought it would pass. But within days, her foot twisted inward, and soon every step became a battle with unbearable pain. Once an athlete trained for marathons, Amanda suddenly found herself unable to walk, trapped in a body that refused to cooperate. After years of failed treatments, she made an unimaginable choice, to have her leg amputated below the knee in the hope of finding freedom from pain. 

Her journey eventually brought her to Abu Dhabi, where she became one of the latest beneficiaries of the 10 Journeys Initiative, a humanitarian program launched by Dr. Shamsheer Vayalil, Founder and Chairman of Burjeel Holdings. The initiative offers 10 free advanced osseointegration prosthetic surgeries for amputees who have lost limbs due to reasons including trauma, illness, or conflict. 

Valued at AED 4 million, the program was introduced as a tribute to Sham and Omar, two children who survived the 2023 Syrian earthquake and were treated at Burjeel Medical City (BMC). All surgeries are performed at BMC’s Al Muderis Osseointegration Clinic, led by world-renowned orthopedic surgeon Prof. Dr. Munjed Al Muderis. Using osseointegration, a technique that anchors a titanium implant directly to the bone, patients gain stability, comfort, and the ability to walk more naturally. With Amanda’s case and two others completed recently, a total of nine patients has now undergone surgery through the initiative. 

Amanda’s fight for independence 

Amanda, 36, had always been active and loved her work training assistance dogs. But after developing Complex Regional Pain Syndrome, her life changed completely. “It reached a point where I cried every morning before getting out of bed,” she said. Over six years, she tried everything from physiotherapy and hydrotherapy to braces and multiple medications. “Nothing worked. Not even a little bit,” Amanda added. 

Living with autism made her situation even more challenging, as she could not tolerate the pressure and heat caused by a traditional socket prosthesis. “The sensory discomfort would have been too much to handle,” she explained. 

Her condition forced her to stop working. Her husband was also unable to work. This sudden loss of income left the family dependent on government aid, making life even harder. “I was the only one supporting our family,” Amanda said. “When I couldn’t work anymore, everything fell apart. We had to survive on subsidies, and there were days I didn’t know what would come next.” 

When she learned about the 10 Journeys Initiative, Amanda saw a lifeline. She travelled to Abu Dhabi alone because her family could not afford to accompany her, leaving behind her husband and home. “From the moment I walked in, everyone at Burjeel was kind and welcoming. The care here is beyond anything I have ever seen,” she said. 

Now, after her surgery, she dreams of returning to dog training and hopes to run again someday. “This surgery has given me the chance to chase life again,” she said quietly. 

A soldier’s second chance 

Steven Doolan, 38, from the United Kingdom, remembers every detail of the day that changed his life. A proud infantry soldier, he was on patrol in Helmand Province, Afghanistan, when an IED exploded beneath him. “I remember the blast, the sound, and then silence. When I looked down, I knew my leg was gone,” he said. Steven lost his right leg in the blast.  

The explosion ended his eight-year military career in an instant. For months, he fought through grueling rehabilitation, learning to walk again with a prosthetic limb. “I was young, strong, and thought I could handle anything, but losing a limb tests you in ways you can’t imagine,” Steven said. 

For more than a decade, he used socket prosthetics that caused pain and discomfort. “On hot days, it would come loose, and I’d have to stop walking. I’d pretend I was fine in front of my kids, but deep down it broke me not being able to play with them or go on family trips without worrying my leg would fall off,” he recalled.  

Steven’s three children, aged 16, 13, and 9, became his motivation to keep pushing. “They never saw me broken. They just wanted their dad to be happy,” he said. When he learned he had been selected for the 10 Journeys Initiative, he said it felt like a new chapter after years of fighting. 

After his surgery, Steven is already regaining strength and balance. “Now I can dream again about running with my kids, going to work, doing things without pain,” he said. “This has given me a chance to be the dad I want to be.” 

Louis’s story of survival 

For Louis Leitao, 68, from Denver, Colorado, life changed just one week after he retired from a 35-year career as a glazier. It was supposed to be a day of simple work on a friend’s ranch. Instead, his parked truck rolled forward and pinned him underneath. He was trapped for nearly 20 hours, alone in the cold. “I screamed until I had no voice left. At one point, I prayed for the pain to stop, even if it meant the end,” he recalled. As the night stretched on, his leg went numb, and his body began to shut down. 

When rescuers finally found him the next morning, his relief was overwhelming. “Hearing the sheriff call my name was the sweetest sound I’ve ever heard,” he said. Louis was airlifted to a trauma center, where doctors amputated his left leg and fought to save his kidneys, which had begun to fail. He spent days on dialysis before his condition stabilized. 

Louis had built his life around physical work and the outdoors. “I used to hike, fish, and walk my dogs every day,” he said. “After the accident, that all stopped. I felt trapped again, this time in a wheelchair.” 

A short residual limb made socket prosthetics unbearable. “I didn’t want to spend my remaining years fighting with pain and poorly fitted prosthetics. Osseointegration gave me a second chance,” he said. At BMC, Louis underwent surgery and is now learning to walk again. He dreams of returning to the mountains, holding a fishing rod, and feeling the ground beneath his feet. 

Prof. Dr. Munjed Al Muderis, who performed the surgeries, said every patient’s recovery shows how advanced technology can transform lives. “Each of these people came here carrying years of pain, loss, and hope. Through osseointegration, we are helping them regain movement and independence,” he said. 

The 10 Journeys Initiative now counts nine patients from across continents among its beneficiaries, including Massimo Castellani (50) from Italy, Alan Mai (49) from Taiwan, Hasnain Ali (24) from Iraq, Anas Jebeihi (30) from Palestine, Joshua Arnold (29) from the United States, and Sharon Cherian (33) from India. 

Hosted by Burjeel Holdings’ Trust Fertility Clinic, the two-day conference explores the emerging techniques and trends in fertility care 

Abu Dhabi, Saturday 13 September 2025: As part of its mission to enhance fertility care in the region, Burjeel Holdings has commenced the Trust Fertility & Gynecology Conference 2025, bringing together leading international and regional experts in reproductive medicine, gynecology, embryology, and fertility technology. Hosted by the Group’s Trust Fertility Clinic, the largest fertility center in the UAE, the inaugural two-day conference is themed ‘Building Trust in Fertility Innovation’ and serves as a platform to exchange knowledge, explore emerging techniques, and discuss ethical frameworks in fertility care. 

The conference was inaugurated by H.E Dr. Sedra Rashed AlMansoori, Member of the Federal National Council (UAE), Member of the Inter-Parliamentary Union Health Committee, and Consultant Family Physician. “Here in the UAE, the subject of this conference is closely aligned with our national priorities. The leadership has declared this year as the ‘Year of Community’, and a dedicated Ministry of Family has been established to enhance stability and cohesion. Her Highness Sheikha Fatima bint Mubarak, the ‘Mother of the Nation’, has long championed family development, child welfare, and women’s empowerment. The UAE, alongside leading institutions such as Burjeel Holdings, has placed fertility and family well-being at the heart of its agenda,” said H.E Dr. Sedra, inaugurating the conference, 

The opening ceremony was also attended by members of the Federal National Council, including H.E. Dr. Amal Al-Haddabi, H.E. Mariam AlZaabi, and H.E. Asma bint Mana Al Otaiba, along with Mr. John Sunil, CEO of Burjeel Holdings, and other senior officials. 

Expert-Led Insights into the Future of Fertility Care 

The two-day conference will bring more than 50 global experts and delegates from over 25 countries for expert-led sessions aimed at enhancing skills and advancing knowledge in reproductive health. It will feature 20 research papers and 19 scientific sessions covering a comprehensive range of topics related to fertility.  

Prior to the conference, six specialized workshops were conducted, offering hands-on training in AI applications in IVF laboratories, hysteroscopy for fertility, Ovarian Tissue Cryopreservation, laparoscopic fertility surgery, and other complex procedures. 

“By bringing global fertility experts together, we are pushing the boundaries of science and technology while fulfilling our commitment to every family who entrusts us with their greatest hope,” said Mr. John Sunil, CEO of Burjeel Holdings. 

Key speakers of the conference include Prof. Alison Campbell, Chief Scientific Officer, CARE Fertility Group, UK, who recently developed an award-winning AI tool to support embryo selection; Prof. Horace Roman, who presented fertility-preserving surgical techniques in endometriosis; and Prof. Osama Shawki, recognized for his innovations in hysteroscopy. Experts from Sheikh Khalifa University are also contributing, providing interdisciplinary perspectives on AI applications in reproductive health. 

“From sperm and embryo selection to preservation techniques, cutting-edge technologies are already demonstrating their ability to enhance key stages of IVF. In the future, the integration of science and technology will allow us to deliver more precise, personalized, and effective treatments. The conference will provide an insightful perspective on this ongoing evolution,” said Dr. Walid Sayed, Group Medical Director, Trust Fertility Clinic. 

Prof. Ahmed Elbohoty, Conference Chairman and Consultant in Obstetrics, Gynecology, and Reproductive Medicine, Trust Fertility Clinic, added that the conference is a unique opportunity to chart the roadmap for the safe and responsible adoption of AI in fertility practices. The insights and evidence presented here will help shape the way the technology is integrated into clinical practice, he noted.